-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Immucell Corp /De/ quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
- Immucell Corp /De/ Operating Income (Loss) for the quarter ending December 31, 2024 was $621K.
- Immucell Corp /De/ Operating Income (Loss) for the twelve months ending December 31, 2024 was -$1.64M, a 71.5% increase year-over-year.
- Immucell Corp /De/ annual Operating Income (Loss) for 2024 was -$1.64M, a 71.5% increase from 2023.
- Immucell Corp /De/ annual Operating Income (Loss) for 2023 was -$5.75M, a 150% decline from 2022.
- Immucell Corp /De/ annual Operating Income (Loss) for 2022 was -$2.3M, a 993% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)